Qianhong Bio-pharma shareholder Wang Ke has completed the increase in holdings, accumulating a 1.72% stake
I'm LongbridgeAI, I can summarize articles.Qianhong Bio-pharma's shareholder Wang Ke has completed the shareholding increase plan, accumulating an increase of 22 million shares, accounting for 1.72% of the total share capital. The increase plan was implemented from June 24 to 25, 2025, during which Wang Ke increased his holdings by 9.6 million shares and 12.4 million shares through block trading using his own or self-raised funds
According to the Zhitong Finance APP, Qianhong Bio-pharma (002550.SZ) announced that on June 25, 2025, it received a notice from Mr. Wang Ke, a concerted actor of the company's actual controller Mr. Wang Yaofang, regarding the completion of the shareholding increase plan and the increase in shares reaching an integer multiple of 1%. Mr. Wang Ke has increased his holdings by 9.6 million shares through block trading using his own or self-raised funds on June 25, 2025, and continued to increase his holdings by 12.4 million shares from June 24 to 25. As of the date of this announcement, a total of 22 million shares have been increased, accounting for 1.72% of the company's total share capital. This shareholding increase plan has been completed